ANIMATION

Bavituximab Mechanism of Action (MOA)

Share this article with:

Together with Peregrine, we helped depict the mechanism of action behind Bavituximab, an investigational treatment that helps the body recognize cancer cells. Upregulated expression of phosphatidylserine by cancer cells contributes to their ability to avoid destruction by the immune system. Bavituximab targets phosphatidylserine, thereby encouraging active immune activity in cancerous environments.

Share It:
Contact XVIVO

Client


Peregrine Pharmaceuticals, Inc.

Both the quality of the final product and my experience working with XVIVO has reinforced my interest in a long-term collaboration with this team.

Alain Viel PhD, Senior Lecturer and Director of Undergraduate Research in Molecular and Cellular Biology, Harvard University